Search - tctmd.com

Displaying 161 - 180 of 388

Sort: Relevancy | Date

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Conference News HRS 2022

Intensive BP Control May Stave Off LV Conduction Disease: SPRINT

Todd Neale

May 02, 2022

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Daily News

Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19

Todd Neale

March 25, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Michael O'Riordan

March 15, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

News Conference News AHA 2021

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Michael O'Riordan

November 22, 2021

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

L.A. McKeown

November 18, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

Advertisement

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Registry Data Hint at MACE Benefit With Renal Denervation

Intensive BP Control May Stave Off LV Conduction Disease: SPRINT

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19

More Evidence Links Breast Arterial Calcification and CVD Risk

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

January 2022 News Roundup

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Another Study Links Stopping Statins to MACE in the Elderly

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content